| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $14.1B | $14.5B | $14.7B | $14.9B | $3.4B | $10.6B | $2.9B | $3.1B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $4.5B | $5.2B | $5.6B | $6.0B | $1.4B | $4.4B | $1.2B | $1.2B |
| Net Income | $2.9B | $3.5B | $3.7B | $4.2B | $0.9B | $2.8B | $0.8B | $0.8B |
| EPS (Basic) | $1.54 | $1.79 | $1.85 | $1.95 | $0.42 | $3.61 | $0.99 | $1.02 |
| EPS (Diluted) | $1.54 | $1.79 | $1.85 | $1.95 | $0.42 | $3.60 | $0.99 | $1.01 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $43.7B | $42.8B | $42.4B | $41.9B | $40.5B | $39.8B | $38.3B | $36.7B |
| Current Assets | $2.5B | $2.8B | $3.4B | $3.8B | $3.9B | $4.4B | $3.3B | $2.6B |
| Cash & Equivalents | — | — | — | $2.0B | $2.2B | $3.1B | $1.0B | $0.9B |
| Total Liabilities | $30.5B | $30.3B | $30.3B | $29.3B | $27.0B | $26.7B | $26.4B | $24.1B |
| Current Liabilities | $3.1B | $3.3B | $3.2B | $2.5B | $2.2B | $2.0B | $2.2B | $1.9B |
| Stockholders' Equity | — | — | — | — | — | — | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $4.6B | $5.2B | $5.5B | $5.6B | $5.1B | $4.3B | $4.8B | $4.6B |
| Investing Cash Flow | $-2.9B | $-2.6B | $-2.3B | $-2.1B | $-1.9B | $-0.6B | $-2.1B | $-1.7B |
| Capital Expenditures | $2.9B | $2.5B | $2.3B | $2.1B | $1.8B | $1.6B | $1.7B | $1.7B |
| Financing Cash Flow | $-2.0B | $-3.1B | $-3.9B | $-3.8B | $-4.1B | $-1.4B | $-2.6B | $-2.5B |